Michael Ball

Board Member, Advisor and Investor

Michael is an accomplished B2B executive with a history of scaling global companies from startup, through acquisition and IPO. Most recently, he was Global VP Informatics at Illumina, a $50B leader in the Genomics space. Prior to that, he was CEO of GenoLogics a venture backed start-up which was sold to Illumina. Michael served on the leadership team at Creo Products, during which time they executed a successful IPO. Currently, Michael focuses his activity as an advisor and board member on companies in the Digital Health sector.